Biogen Idec researchers identify novel approach for promoting Remyelination
3 July 2011 | By Biogen Idec
Results from a study that suggest that inhibiting death receptor-6 (DR6) function may represent a novel approach...
List view / Grid view
News
Lilly Quality Leader Walsh appointed to Company’s Executive Committee
1 July 2011 | By Eli Lilly and Company
Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company on July 1...
Lundbeck appoints Senior Vice President of HR
1 July 2011 | By H. Lundbeck A/S
H. Lundbeck A/S has appointed Teddy Hebo Larsen as Senior Vice President of HR...
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
Merck statement on voluntary submission of clinical research protocols
1 July 2011 | By Merck
For its investigational and approved products...
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
1 July 2011 | By GlaxoSmithKline
GSK announced that its rotavirus vaccine has received approval in Japan...
AstraZeneca’s NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
1 July 2011 | By AstraZeneca
NEXIUM 10 mg and 20 mg capsules have received regulatory approval in Japan...
Merck receives approval to market GARDASIL®, ZOLINZA® and CUBICIN®
1 July 2011 | By Merck
Merck announced that the Japanese MHLW approved three products – GARDASIL®, ZOLINZA® and CUBICIN®...
Novartis receives approval in Japan for Onbrez® Inhalation Capsules
1 July 2011 | By Novartis
Novartis has received regulatory approval in Japan for Onbrez® Inhalation Capsules (indacaterol)...
Thermo Fisher Scientific recognised as winner of the 2011 Microsoft Life Sciences Innovation Awards
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is a 2011 winner of Microsoft Corporation’s Life Sciences Innovation Awards. This is the fourth consecutive year that the company has been recognized by Microsoft, demonstrating Thermo Fisher’s leading position as a provider of innovative enterprise…
Novartis Phase III study shows once-daily NVA237 is superior to placebo
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
Pfizer announces data presentations for investigational compounds in its lung cancer portfolio
29 June 2011 | By Pfizer
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio...
AstraZeneca and PTC announce strategic oncology drug discovery collaboration
29 June 2011 | By AstraZeneca
AstraZeneca & PTC have entered into an exclusive research collaboration & license agreement...
Tecan launches Tecan Award 2011
29 June 2011 | By kdm communications limited
Tecan announced that entries are now open for the 2011 Tecan Award. The Tecan Award is designed to celebrate the innovation and ingenuity of Tecan’s loyal customers...
Macmillan responds to NICE’s decision not to recommend lung cancer drug
29 June 2011 | By Macmillan Cancer Support
Mike Hobday, Head of Policy at Macmillan Cancer Support, said...
